Serostim Lq

   
Google
 
Web NewDrugInformation.com

Serostim Lq


Drug - Serostim Lq
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; SUBCUTANEOUS
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Somatropin Recombinant
Multiple ingredients are in alphabetical order.

Strength - 6MG/0.5ML
The potency of the active ingredient(s), Somatropin Recombinant. May repeat for multiple part products.

Applicant - SERONO
The firm name holding legal responsibility for Serostim Lq. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020604
The FDA assigned number to Serostim Lq. Format is nnnnnn.

Product Number - 005
The FDA assigned number to identify Serostim Lq. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 11, 2005
The date Serostim Lq was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Serostim Lq. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Serostim Lq is in. Format is RX, OTC, DISCN.

Applicant Full Name - Serono Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Serostim Lq.

Serostim Lq